Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker ROOT
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 780,727 | 5.4% | SCHEDULE 13D/A ↗ |
| Sep 2, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 780,727 | 5.4% | SCHEDULE 13D/A ↗ |
| Sep 2, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 780,727 | 5.4% | SCHEDULE 13D/A ↗ |
| Jul 29, 2026 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | BlackRock, Inc. | 1.01M | 7.2% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | T. Rowe Price Investment Management, Inc. | 1.19M | 8.6% | SCHEDULE 13G/A ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 3.71M | 21.2% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 3.71M | 21.2% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 3.71M | 21.2% | SCHEDULE 13D/A ↗ |
| Oct 30, 2025 | SCHEDULE 13G | ROOT Root, Inc. | The Vanguard Group | 724,541 | 5.3% | SCHEDULE 13G ↗ |
| Sep 2, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 2.22M | 14.0% | SCHEDULE 13D/A ↗ |
| Sep 2, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 2.22M | 14.0% | SCHEDULE 13D/A ↗ |
| Sep 2, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 2.22M | 14.0% | SCHEDULE 13D/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Christopher Olsen | 307,732 | 2.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Purple Dot, LLC | 151,569 | 1.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Dwight H. Hibbard Family Trust f/b/o Christopher Olsen - Exempt | 6,869 | 0.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | DC I Investment, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Drive Capital, LLC | 149,294 | 1.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Drive Capital Overdrive Fund I (GP), LLC | 149,294 | 1.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Drive Capital Overdrive Ignition Fund I, L.P. | 1,406 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Drive Capital Overdrive Fund I (TE), L.P. | 48,201 | 0.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Drive Capital Overdrive Fund I, L.P. | 99,687 | 0.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Meyer Malka | 1.23M | 8.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital GP, Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital GP, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Ribbit Capital GP IV, Ltd. | 1.23M | 8.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Ribbit Capital GP IV, L.P. | 1.23M | 8.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | RT-E Ribbit Opportunity IV, LLC | 235,824 | 1.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Ribbit Capital IV, L.P. | 996,783 | 7.1% | SCHEDULE 13G/A ↗ |
| Aug 8, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 7.95M | 36.9% | SCHEDULE 13D/A ↗ |
| Aug 8, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 7.95M | 36.9% | SCHEDULE 13D/A ↗ |
| Aug 8, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 7.95M | 36.9% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Alexander E. Timm | 1.14M | 7.8% | SCHEDULE 13G/A ↗ |
| May 14, 2025 | SCHEDULE 13G | ROOT Root, Inc. | T. Rowe Price Investment Management, Inc. | 679,696 | 6.1% | SCHEDULE 13G ↗ |
| May 13, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 7.95M | 39.7% | SCHEDULE 13D/A ↗ |
| May 13, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 7.95M | 39.7% | SCHEDULE 13D/A ↗ |
| May 13, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 7.95M | 39.7% | SCHEDULE 13D/A ↗ |
| Mar 6, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | SVB Capital Management, LLC | 0 | 4.7% | SCHEDULE 13G/A ↗ |
| Feb 28, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. | 7.95M | 41.5% | SCHEDULE 13D/A ↗ |
| Feb 28, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Co. Sub LLC | 7.95M | 41.5% | SCHEDULE 13D/A ↗ |
| Feb 28, 2025 | SCHEDULE 13D/A (amended) | ROOT Root, Inc. | Carvana Group, LLC | 7.95M | 41.5% | SCHEDULE 13D/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Alexander E. Timm | 1.12M | 9.2% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Meyer Malka | 1.46M | 12.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital GP, Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital GP, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Bullfrog Capital, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Ribbit Capital GP IV, Ltd. | 1.46M | 12.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | Ribbit Capital GP IV, L.P. | 1.46M | 12.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | ROOT Root, Inc. | RT-E Ribbit Opportunity IV, LLC | 235,824 | 2.2% | SCHEDULE 13G/A ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances